Interaction ID
ncRI-40660376
Interaction Molecules
hsa-miR-138-2-3p -- DUSP16
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000111266
Description
Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2.
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-138-2-3p | Alzheimer's disease | MNDR Database |
hsa-miR-138-2-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-138-2-3p | anencephaly | MNDR Database |
hsa-miR-138-2-3p | arthritis | MNDR Database |
hsa-miR-138-2-3p | astrocytoma | MNDR Database |
hsa-miR-138-2-3p | autosomal recessive disease | MNDR Database |
hsa-miR-138-2-3p | B-cell lymphoma | MNDR Database |
hsa-miR-138-2-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-138-2-3p | bone disease | MNDR Database |
hsa-miR-138-2-3p | brain disease | MNDR Database |
hsa-miR-138-2-3p | breast cancer | MNDR Database |
hsa-miR-138-2-3p | Breast Neoplasms | MNDR Database |
hsa-miR-138-2-3p | Burkitt lymphoma | MNDR Database |
hsa-miR-138-2-3p | cancer | MNDR Database |
hsa-miR-138-2-3p | carcinoma | MNDR Database |
hsa-miR-138-2-3p | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-138-2-3p | chronic lymphocytic leukemia | MNDR Database |
hsa-miR-138-2-3p | chronic myeloid leukemia | MNDR Database |
hsa-miR-138-2-3p | colon cancer | MNDR Database |
hsa-miR-138-2-3p | colorectal cancer | MNDR Database |
hsa-miR-138-2-3p | connective tissue disease | MNDR Database |
hsa-miR-138-2-3p | cystic nephroma | MNDR Database |
hsa-miR-138-2-3p | diabetes mellitus | MNDR Database |
hsa-miR-138-2-3p | esophageal cancer | MNDR Database |
hsa-miR-138-2-3p | eye disease | MNDR Database |
hsa-miR-138-2-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-138-2-3p | fragile X syndrome | MNDR Database |
hsa-miR-138-2-3p | gallbladder carcinoma | MNDR Database |
hsa-miR-138-2-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-138-2-3p | gastric lymphoma | MNDR Database |
hsa-miR-138-2-3p | Glioblastoma | MNDR Database |
hsa-miR-138-2-3p | head and neck cancer | MNDR Database |
hsa-miR-138-2-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | heart disease | MNDR Database |
hsa-miR-138-2-3p | Heart Failure | MNDR Database |
hsa-miR-138-2-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-138-2-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-138-2-3p | HIV | MNDR Database |
hsa-miR-138-2-3p | Huntington's disease | MNDR Database |
hsa-miR-138-2-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-138-2-3p | hypertension | MNDR Database |
hsa-miR-138-2-3p | intellectual disability | MNDR Database |
hsa-miR-138-2-3p | kidney disease | MNDR Database |
hsa-miR-138-2-3p | large cell neuroendocrine cancer | MNDR Database |
hsa-miR-138-2-3p | leukemia | MNDR Database |
hsa-miR-138-2-3p | liver disease | MNDR Database |
hsa-miR-138-2-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-138-2-3p | lung cancer | MNDR Database |
hsa-miR-138-2-3p | lung disease | MNDR Database |
hsa-miR-138-2-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | Lymphoblastoid | MNDR Database |
hsa-miR-138-2-3p | lymphoma | MNDR Database |
hsa-miR-138-2-3p | Lymphoma, Non-Hodgkin | MNDR Database |
hsa-miR-138-2-3p | malignant glioma | MNDR Database |
hsa-miR-138-2-3p | malignant pleural mesothelioma | MNDR Database |
hsa-miR-138-2-3p | medulloblastoma | MNDR Database |
hsa-miR-138-2-3p | medulloepithelioma | MNDR Database |
hsa-miR-138-2-3p | melanoma | MNDR Database |
hsa-miR-138-2-3p | Multiple Sclerosis, Chronic Progressive | MNDR Database |
hsa-miR-138-2-3p | myeloid leukemia | MNDR Database |
hsa-miR-138-2-3p | Myocardial Ischemia | MNDR Database |
hsa-miR-138-2-3p | myopathy | MNDR Database |
hsa-miR-138-2-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-138-2-3p | Neoplasms | MNDR Database |
hsa-miR-138-2-3p | nephroblastoma | MNDR Database |
hsa-miR-138-2-3p | neuroblastoma | MNDR Database |
hsa-miR-138-2-3p | neurodegenerative disease | MNDR Database |
hsa-miR-138-2-3p | Neuroendocrine Tumors | MNDR Database |
hsa-miR-138-2-3p | non-Hodgkin lymphoma | MNDR Database |
hsa-miR-138-2-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | osteoarthritis | MNDR Database |
hsa-miR-138-2-3p | osteosarcoma | MNDR Database |
hsa-miR-138-2-3p | ovarian carcinoma | MNDR Database |
hsa-miR-138-2-3p | ovarian clear cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-138-2-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-138-2-3p | pancreatic cancer | MNDR Database |
hsa-miR-138-2-3p | panic disorder | MNDR Database |
hsa-miR-138-2-3p | papillary thyroid carcinoma | MNDR Database |
hsa-miR-138-2-3p | Parkinson's disease | MNDR Database |
hsa-miR-138-2-3p | Peripheral Nervous System Diseases | MNDR Database |
hsa-miR-138-2-3p | pituitary adenoma | MNDR Database |
hsa-miR-138-2-3p | pleuropulmonary blastoma | MNDR Database |
hsa-miR-138-2-3p | Precursor Cell Lymphoblastic Leukemia-Lymphoma | MNDR Database |
hsa-miR-138-2-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-138-2-3p | Prostatic Neoplasms | MNDR Database |
hsa-miR-138-2-3p | psoriasis | MNDR Database |
hsa-miR-138-2-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-138-2-3p | renal cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | retinoblastoma | MNDR Database |
hsa-miR-138-2-3p | Sertoli-Leydig cell tumor | MNDR Database |
hsa-miR-138-2-3p | skin disease | MNDR Database |
hsa-miR-138-2-3p | skin melanoma | MNDR Database |
hsa-miR-138-2-3p | Sleep Deprivation | MNDR Database |
hsa-miR-138-2-3p | squamous cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | stomach cancer | MNDR Database |
hsa-miR-138-2-3p | T-cell leukemia | MNDR Database |
hsa-miR-138-2-3p | temporal lobe epilepsy | MNDR Database |
hsa-miR-138-2-3p | thyroid cancer | MNDR Database |
hsa-miR-138-2-3p | thyroid carcinoma | MNDR Database |
hsa-miR-138-2-3p | thyroid Hurthle cell carcinoma | MNDR Database |
hsa-miR-138-2-3p | Thyroid Carcinoma, Anaplastic | MNDR Database |
hsa-miR-138-2-3p | type 2 diabetes mellitus | MNDR Database |
hsa-miR-138-2-3p | Urinary Bladder Neoplasms | MNDR Database |
hsa-miR-138-2-3p | Uterine Cervical Neoplasms | MNDR Database |
hsa-miR-138-2-3p | vascular disease | MNDR Database |
hsa-miR-138-2-3p | X-linked disease | MNDR Database |